Combination of cyclophosphamide and estrogen therapy in DMBA-induced rat mammary cancer.
D000818:Animals; D001551:Benz(a)Anthracenes; D002454:Cell Differentiation; D002455:Cell Division; D003520:Cyclophosphamide / Q000008:administration & dosage*; D004273:DNA, Neoplasm / Q000096:biosynthesis; D004054:Diethylstilbestrol / Q000037:antagonists & inhibitors; D004965:Estrogen Antagonists; D004967:Estrogens / Q000008:administration & dosage; D005260:Female; D008325:Mammary Neoplasms, Experimental / Q000139:chemically induced / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D009365:Neoplasm Regression, Spontaneous; D010759:Phosphorus Isotopes; D012334:RNA, Neoplasm / Q000096:biosynthesis; D051381:Rats; D013268:Stimulation, Chemical
D001551:Benz(a)Anthracenes; D004273:DNA, Neoplasm; D004965:Estrogen Antagonists; D004967:Estrogens; D010759:Phosphorus Isotopes; D012334:RNA, Neoplasm; D004054:Diethylstilbestrol; D003520:Cyclophosphamide